Wu H, Ding X, Zhang Y, Li W, Chen J
J Clin Hypertens (Greenwich). 2022; 24(6):667-676.
PMID: 35538636
PMC: 9180318.
DOI: 10.1111/jch.14463.
Cheng Y, Bai C, Xu J, Shen L, Li J, Zhou Z
ESMO Open. 2022; 7(2):100453.
PMID: 35344750
PMC: 9058866.
DOI: 10.1016/j.esmoop.2022.100453.
Ting J, Lo Z
BMJ Case Rep. 2021; 14(10).
PMID: 34706918
PMC: 8552176.
DOI: 10.1136/bcr-2021-245653.
Xu H, Liu Q
Onco Targets Ther. 2021; 13:13345-13355.
PMID: 33456310
PMC: 7804055.
DOI: 10.2147/OTT.S279998.
Patwari A, Bhatlapenumarthi V, Pascual S
Case Rep Oncol. 2020; 13(2):1013-1019.
PMID: 32999665
PMC: 7506375.
DOI: 10.1159/000509640.
Resistant Hypertension Updated Guidelines.
Chernova I, Krishnan N
Curr Cardiol Rep. 2019; 21(10):117.
PMID: 31471727
DOI: 10.1007/s11886-019-1209-6.
Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors.
Li J, Wang M, Zhang B, Wu X, Lin T, Liu X
World J Gastroenterol. 2018; 24(46):5189-5202.
PMID: 30581268
PMC: 6295840.
DOI: 10.3748/wjg.v24.i46.5189.
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.
Carey R, Calhoun D, Bakris G, Brook R, Daugherty S, Dennison-Himmelfarb C
Hypertension. 2018; 72(5):e53-e90.
PMID: 30354828
PMC: 6530990.
DOI: 10.1161/HYP.0000000000000084.
Hypertension in malignancy-an underappreciated problem.
Malyszko J, Malyszko M, Kozlowski L, Kozlowska K, Malyszko J
Oncotarget. 2018; 9(29):20855-20871.
PMID: 29755695
PMC: 5945504.
DOI: 10.18632/oncotarget.25024.
Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma.
Di Costanzo G, Casadei Gardini A, Marisi G, Foschi F, Scartozzi M, Granata R
Target Oncol. 2017; 12(6):795-803.
PMID: 28770532
DOI: 10.1007/s11523-017-0522-5.
Renal cell carcinoma: new insights and challenges for a clinician scientist.
Shingarev R, Jaimes E
Am J Physiol Renal Physiol. 2017; 313(2):F145-F154.
PMID: 28381462
PMC: 5582896.
DOI: 10.1152/ajprenal.00480.2016.
Sunitinib in the treatment of metastatic renal cell carcinoma.
Schmid T, Gore M
Ther Adv Urol. 2016; 8(6):348-371.
PMID: 27904651
PMC: 5117167.
DOI: 10.1177/1756287216663979.
Impact of concomitant medications on obstructive sleep apnoea.
Jullian-Desayes I, Revol B, Chareyre E, Camus P, Villier C, Borel J
Br J Clin Pharmacol. 2016; 83(4):688-708.
PMID: 27735059
PMC: 5346880.
DOI: 10.1111/bcp.13153.
Incidence and risk of hypertension associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a comprehensive network meta-analysis of 72 randomized controlled trials involving 30013 patients.
Liu B, Ding F, Liu Y, Xiong G, Lin T, He D
Oncotarget. 2016; 7(41):67661-67673.
PMID: 27602778
PMC: 5341903.
DOI: 10.18632/oncotarget.11813.
Prevention of fostamatinib-induced blood pressure elevation by antihypertensive agents.
Lengel D, Lamm Bergstrom E, Barthlow H, Oldman K, Musgrove H, Harmer A
Pharmacol Res Perspect. 2015; 3(5):e00176.
PMID: 26516588
PMC: 4618647.
DOI: 10.1002/prp2.176.
In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib.
Rolf M, Curwen J, Veldman-Jones M, Eberlein C, Wang J, Harmer A
Pharmacol Res Perspect. 2015; 3(5):e00175.
PMID: 26516587
PMC: 4618646.
DOI: 10.1002/prp2.175.
Getting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer Therapy.
Hamo C, Bloom M
Clin Med Insights Cardiol. 2015; 9(Suppl 2):47-51.
PMID: 26309419
PMC: 4525792.
DOI: 10.4137/CMC.S19704.
Non-interventional management of resistant hypertension.
Doumas M, Tsioufis C, Faselis C, Lazaridis A, Grassos H, Papademetriou V
World J Cardiol. 2014; 6(10):1080-90.
PMID: 25349652
PMC: 4209434.
DOI: 10.4330/wjc.v6.i10.1080.
VEGF and eNOS expression in umbilical cord from pregnancy complicated by hypertensive disorder with different severity.
Bhavina K, Radhika J, Pandian S
Biomed Res Int. 2014; 2014:982159.
PMID: 24959596
PMC: 4053217.
DOI: 10.1155/2014/982159.
Olmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich's ascites carcinoma: role of angiotensin (1-7).
Abd-Alhaseeb M, Zaitone S, Abou-El-Ela S, Moustafa Y
PLoS One. 2014; 9(1):e85891.
PMID: 24465768
PMC: 3899087.
DOI: 10.1371/journal.pone.0085891.
